Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabrina Rizzo

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 16, 2020
Detailed In Vitro Pharmacological Characterization of the Clinically Viable Nociceptin/Orphanin FQ Peptide Receptor Antagonist BTRX-246040Federica Ferrari, Sabrina Rizzo, Chiara Ruzza, et al.
Microorganisms|March 26, 2022
Innate Immune Response in SARS-CoV-2 InfectionGiovanna Schiuma, Silvia Beltrami, Daria Bortolotti, et al.
Cells|August 30, 2020
SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A PathwayDaria Bortolotti, Valentina Gentili, Sabrina Rizzo, et al.
Microorganisms|June 15, 2023
SARS-CoV-2 Systemic Effects: New CluesSilvia Beltrami, Sabrina Rizzo, Francesca Caccuri, et al.
Microorganisms|July 29, 2023
Gestational Viral Infections: Role of Host Immune SystemSilvia Beltrami, Sabrina Rizzo, Giovanna Schiuma, et al.
Pathogens (Basel, Switzerland)|August 28, 2025
Immune Modulation by Microbiota and Its Possible Impact on Polyomavirus InfectionGiorgia Cianci, Gloria Maini, Matteo Ferraresi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 24, 2022
Humoral and adaptive immune responses to the SARS-CoV-2 vaccineRoberta Rizzo, Daria Bortolotti, Luca Morandi, et al.
Current Therapeutic Research, Clinical and Experimental|March 21, 2024
Comparison Between Moxifloxacin and Chloramphenicol for the Treatment of Bacterial Eye InfectionsValentina Gentili, Giovanni Strazzabosco, Rossella Spena, et al.
Human Immunology|April 2, 2023
Non-classical HLA class I molecules and their potential role in viral infectionsSilvia Beltrami, Sabrina Rizzo, Giovanni Strazzabosco, et al.
Microorganisms|January 28, 2026
SARS-CoV-2 Infection Associated with HHV-6A Reactivation and an Inhibitory KIR2DL2/HLA-C1 Immunogenetic ProfileSabrina Rizzo, Matteo Ferraresi, Giovanni Strazzabosco, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Pharmacology and Experimental Therapeutics|January 16, 2020
Detailed In Vitro Pharmacological Characterization of the Clinically Viable Nociceptin/Orphanin FQ Peptide Receptor Antagonist BTRX-246040Federica Ferrari, Sabrina Rizzo, Chiara Ruzza, et al.
Microorganisms|March 26, 2022
Innate Immune Response in SARS-CoV-2 InfectionGiovanna Schiuma, Silvia Beltrami, Daria Bortolotti, et al.
Cells|August 30, 2020
SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A PathwayDaria Bortolotti, Valentina Gentili, Sabrina Rizzo, et al.
Microorganisms|June 15, 2023
SARS-CoV-2 Systemic Effects: New CluesSilvia Beltrami, Sabrina Rizzo, Francesca Caccuri, et al.
Microorganisms|July 29, 2023
Gestational Viral Infections: Role of Host Immune SystemSilvia Beltrami, Sabrina Rizzo, Giovanna Schiuma, et al.
Pathogens (Basel, Switzerland)|August 28, 2025
Immune Modulation by Microbiota and Its Possible Impact on Polyomavirus InfectionGiorgia Cianci, Gloria Maini, Matteo Ferraresi, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 24, 2022
Humoral and adaptive immune responses to the SARS-CoV-2 vaccineRoberta Rizzo, Daria Bortolotti, Luca Morandi, et al.
Current Therapeutic Research, Clinical and Experimental|March 21, 2024
Comparison Between Moxifloxacin and Chloramphenicol for the Treatment of Bacterial Eye InfectionsValentina Gentili, Giovanni Strazzabosco, Rossella Spena, et al.
Human Immunology|April 2, 2023
Non-classical HLA class I molecules and their potential role in viral infectionsSilvia Beltrami, Sabrina Rizzo, Giovanni Strazzabosco, et al.
Microorganisms|January 28, 2026
SARS-CoV-2 Infection Associated with HHV-6A Reactivation and an Inhibitory KIR2DL2/HLA-C1 Immunogenetic ProfileSabrina Rizzo, Matteo Ferraresi, Giovanni Strazzabosco, et al.
Pageof 4